The Batch Record Bottleneck in Life Sciences:

Identifying and Resolving the Disconnected Data Breaking Your Processes

See How Disconnected Data Is Slowing Your Manufacturing, Jeopardizing Audit Readiness, and Blocking AI.

One batch. Six stages. Two realities. Scroll to see what changes when everything works as one.

The life sciences industry’s biggest AI enabler is also its biggest blocker.

Nearly 60% of life sciences organizations say integration is essential for deploying AI. But integration issues with existing systems are also the No. 1 barrier. The batch record is where that paradox becomes a daily cost.

1

manual 1%

2

digital 56%

3

connected 41%

4

intelligent 0%

A minority of life sciences professionals surveyed report having connected systems.i

The gap between Connected and Intelligent isn’t an AI problem. It’s a connectivity problem. Let’s look at it through the lens of the batch record.

Inspections are rising.
Readiness isn’t.

Drug quality inspections are up 28%. Device inspections are up 8%. And AI-enabled regulators are giving less notice than ever before.

95%

of organizations report quarantine and delays in product release due to long QA reviews where product sits while reviewers gather data from multiple systems.i

The connected batch.

Not retrofitted integrations. One platform, built from the ground up so quality, manufacturing, and asset data work as one.

One data thread. Six stages. Two realities.

One connected batch. Two regulatory frameworks.

Built on a natively connected platform rather than retrofitted integrations, the connected batch adapts to each regulatory framework.

21 CFR Parts 210–211 · ALCOA++

  • Batch record integrity across the full lifecycle.
  • Deviation context preserved in-line, not reconstructed.
  • ALCOA++ data integrity by construction.
  • Continuous inspection readiness for drug manufacturing.

QMSR · ISO 13485

  • Asset readiness (PM schedules, calibration traceability, and equipment qualification) connected to the batch thread under QMSR / ISO 13485.
  • Production records connected to design history — not just corrective action/preventive action (CAPA).
  • QMSR / ISO 13485 traceability without manual reconciliation.
  • Ready for risk-tiered, targeted device inspections.
28% / 8%

drug vs. device inspection growth FY2025.ii,iii

The moment before execution begins.

Is the line ready? The answer depends on whether readiness is assumed — or verified.

Readiness checked across separate systems. The batch starts with assumptions.

  • Master data, SOPs, and equipment status maintained in separate systems.
  • Manual confirmation, recorded separate from the batch.
  • No qualification check before the line starts.

One pre-flight checklist. The line can’t start until every condition is met and recorded in the same thread.

  • Production records status check integrated with asset management system.
  • In-line training automatically verified against quality system.
  • Quality events flagged before execution — the line won’t start if a pending event impacts readiness.
  • Every condition recorded in the batch thread.
93%

of manufacturing professionals report that their production systems operate in silos, unable to share data seamlessly or provide unified visibility into operations.i

"I just want to know I'm cleared to start. In the connected world, the system tells me — equipment's good, I'm trained, the recipe's current. I'm not guessing, and I'm not the one who gets blamed when something's out of date."

"Readiness is where compliance is won or lost. When training and calibration are verified in-line before a step executes, I stop chasing preventable deviations and start trusting the floor."

“One platform means one validation scope, one upgrade path. I'm not reconciling three systems to confirm an operator is qualified. It's the same governed data, everywhere.”

What Connected Pharma Readiness Looks Like:
  • One pre-flight checklist pulls master data, current SOPs, and equipment calibration status from one platform.
  • ALCOA++ integrity verified in-line before the line starts; qualification confirmed, not assumed.
  • Always-current master batch record under 21 CFR 210–211, ready for rising drug quality inspections.
What Connected Medical Device Readiness Looks Like:
  • Production readiness connected to design controls and device history record (DHR) requirements under QMSR / ISO 13485.
  • Equipment calibration and training status linked directly to the device history record.
  • Risk-tiered device inspections met with verified, connected readiness from the start.

The batch is running.

Does the record show what is actually happening? Or is it what someone transcribed later?

Paper. Illegible entries. Manual math. The record is always one step behind reality.

  • Offline capture, transcribed later.
  • Each transcription is an ALCOA++ risk.
  • Errors caught only at review.
  • Quality applied retroactively.

Real-time electronic capture. The record is the execution. No transcription gaps.

  • Errors stopped at the moment they could happen.
  • Guided work instructions, step by step.
  • Automated calculations and field verification.
  • Real-time, structured, audit-ready capture.
95%

of life sciences manufacturing professionals report having compliance issues with GMP documentation and data integrity.i

“The screen walks me through each step. It won't let me move on if a value's off or I haven't confirmed a check. It's not more work — it's less, because I'm not second-guessing or redoing entries later.”

“When the record is built right at the point of execution, my review becomes about exceptions, not reconstruction. I'm not assembling evidence — I'm reading a clean, complete record.”

“Right first time isn't a slogan; it's throughput. Every error caught on the floor is a deviation, a delay, and a cost we never incur.”

What Connected Pharma Execution Looks Like:
  • Real-time electronic capture with electronic signatures and timestamps written directly to the thread.
  • ALCOA++ integrity built in at the point of execution under 21 CFR 210–211 — no transcription gap.
  • Guided work instructions and auto-populated fields stop errors before they happen.
What Connected Medical Device Execution Looks Like:
  • Production execution and device history captured in one connected record under QMSR / ISO 13485.
  • Production data captured for the eDHR while asset management feeds equipment status and calibration — all flowing to quality for documentation and audit trail.
  • Field verification ensures every step meets design input requirements as it happens.

Something goes wrong mid-batch.

This is the inflection point — where disconnection doesn’t just slow you down, it cascades risk.

Documented in a separate QMS. Reconciled back to the batch by hand. The audit thread breaks.

  • Context scattered across multiple systems.
  • Manual reconciliation delays investigation.
  • The batch waits while quality reconstructs.

Triggers directly from the batch record. Stays attached for life. The connection is never lost.

  • One investigation across all domains.
  • Quality notified immediately, decisions come faster.
  • The batch keeps moving.
97%

of life sciences manufacturing professionals can’t predict quality issues before they occur.i

“The deviation comes to me with the batch, the operator, and the equipment already linked. I spend my time making decisions, not hunting for information.”

“I flag it once, in the moment, and the right people see it instantly. I'm not filling out a separate form and hoping someone finds it later.”

“Every deviation that drags on is production capacity I can't get back. When the investigation is connected and fast, my team spends time manufacturing, not reconstructing what happened.”

What Connected Deviation Management Looks Like in Pharma:
  • Deviation links directly between the batch record and the QMS with full context intact under 21 CFR 210–211.
  • One investigation surfaces batch history, operator qualification, and equipment maintenance simultaneously.
  • The batch keeps moving; release no longer stalls while quality reconstructs.
What Connected Deviation Management Looks Like in Medical Device:
  • Deviation launched directly from the shop floor and connected to any future CAPAs in one platform.
  • Root cause investigation automatically includes all connected data like batch, operator, asset, and process that governed it.
  • Traceability from event to investigation to resolution is never lost.

The batch is done.
Now quality reviews it.

Is release a rebuild or merely a review? This is where hours become days — or minutes.

A reconciliation project. Pull, assemble, check, sign. The scramble is what inspectors see.

  • Manual assembly from multiple sources.
  • Reviewers hunt for exceptions by eye.
  • Release measured in days, not minutes.

A review, not a rebuild. The thread is already assembled. Review by exception surfaces only what matters.

  • Only exceptions surface for review.
  • The thread already exists — no rebuild necessary.
  • Release in minutes, audit ready by design.
75%-85%

less time spent reviewing batch records with electronic batch records and review by exception.iv

“Review by exception changes the job entirely. Now I look at the few things that went wrong, not everything that went right. Release used to be my backlog; now it's a checkpoint.”

“Because the record was built in a validated system, release doesn't trigger a separate validation effort. It's all the same governed data.”

“Faster release means product reaches patients sooner and working capital isn't tied up in batches waiting on a desk.”

What Connected Release Looks Like in Pharma:
  • Release is a review, not a rebuild; the complete digital thread from execution to review is already assembled under 21 CFR 210–211.
  • Review by exception surfaces only what matters; release in minutes, audit-ready by design.
  • Auditors see a clean, complete record, not a scramble.
What Connected Release Looks Like in Medical Device:
  • Release is a review of a complete production record that already exists, with full lineage across the entire production process.
  • Quality standards verified automatically at release — every step, signature, and equipment reading already connected and audit-ready.
  • Risk-tiered device inspections met with an always-current, inspection-ready thread.

Step back and see the whole batch as one unbroken record.

Equipment events, operational history, and batch execution — either broken by paper gaps or connected as a single thread.

The thread is broken by paper. Equipment events, operational history, and batch execution live in separate systems. Every audit means reassembling evidence from multiple disparate systems before an inspection.

  • Data siloed across equipment, ops, and batch.
  • Manual reconciliation for every audit.
  • Scrambling the week before an inspection.

One continuous thread, from equipment event to batch release. When production records, logbooks, QMS, and asset management work together on one platform, the team gets a complete digital thread — no paper gaps, no manual reconciliation, always-on audit readiness.

  • Equipment, ops, and batch on a single thread.
  • No manual reconciliation across disconnected systems.
  • Always-on audit readiness.
<10 minutes

batch genealogy reconstruction time, compared to 2-4 hours with paper.iv

One data thread. Two possibilities.

Disconnected: the broken thread

Every system is its own island. Data crosses on paper, by hand, late.

Equipment· gap ·Logbook· gap ·Batch· gap ·QMS

Connected: the continuous thread

One data model, one governed foundation. Data flows in real time, never leaves compliance boundaries.

EquipmentLogbookBatchQMSRelease

“An audit used to be a fire drill. Now the evidence already exists, complete and unaltered, from the moment the work was performed.”

“When the thread is broken, every audit means pulling my people off the floor to chase records across five systems. When it's connected, the evidence is already there, meaning my team stays on the floor, and the batch keeps moving.”

“Audit readiness is a strategic asset. It's how we defend market access and protect the pipeline. The digital thread isn't an IT project; it's enterprise risk management.”

What the Connected Digital Thread Looks Like in Pharma:
  • The audit thread already exists. Every signature, reading, and change connected and timestamped under 21 CFR 210–211.
  • Walk into any drug quality inspection with complete confidence. The evidence is complete and unaltered.
  • Inspection readiness is a state, not an event; ready for FDA HALO/Elsa 4.0 AI-scale visibility.
What the Connected Digital Thread Looks Like in Medical Device:
  • One continuous thread from design controls through CAPA to batch release under QMSR / ISO 13485.
  • Traceability without manual reconciliation; the thread is always current and inspection-ready.
  • Risk-tiered device inspections met with a digital thread that holds up under targeted review.

What makes it all connected?

One governed intelligence layer. One platform. One data model.

The ideal platform unifies quality, manufacturing, and asset management data within a single, governed environment — with ISO 42001-certified AI infrastructure embedded, not bolted on. Data never leaves compliance boundaries and is never used for training models. Analytics are built in: a single, AI-ready semantic data layer powers real-time dashboards and predictive insights out of the box, not through a separate analytics layer.

  • Native connectivity — not layered on top.
  • Unified data and connected processes across quality, manufacturing, and assets.
  • Simplified validation. One validation footprint, not one per system.
  • Analytics built in, not a separate analytics layer.
  • Easy to integrate with other existing systems.
  • Production-grade manufacturing execution — guided work instructions, not just electronic forms.

“One platform means one validation scope, one upgrade path. Now we have full confidence in governed change management that holds up under inspection.”

“AI is only as good as the data behind it. When quality, manufacturing, and asset data are unified on one governed model, AI stops being a pilot and starts being something we can actually trust in production.”

“This is the foundation that turns our digital investment into AI readiness. It’s about having the right architecture, not spending more.”

What Connected Intelligence Looks Like in Pharma:
  • AI runs on unified, governed batch record data under 21 CFR 210–211, the trustworthy foundation AI needs to act.
  • Quality, manufacturing, and asset data on one governed model — the missing step to Intelligent operations.
  • ISO 42001-certified AI infrastructure embedded, not bolted on. Intelligence you can trust in.
What the Connected Digital Thread Looks Like in Medical Device:
  • AI connected to design controls and production history under QMSR / ISO 13485; decisions grounded in governed data.
  • One validation scope for AI-driven quality decisions. Validation is an accelerator, not a blocker.
  • Analytics built in: connected data powers predictive insights natively, not through a separate layer.

All together, now.

Qx · Quality
Mx · Manufacturing
Ax · Assets

MasterControl offers the platform, the data, the community — connected.

When quality, manufacturing, and asset data work as one, the batch stops being a bottleneck and starts being a foundation.

  • Natively unified QMS + MES + CMMS platform.
  • ISO 42001-certified AI infrastructure embedded at the system-of-record layer.
  • 1,300-plus customers worldwide.

Intelligence you can trust. Validation that accelerates. Already load-bearing for the life sciences industry’s largest, most scrutinized companies.

One batch. One thread. Your move.

Want to see what Connected Intelligence could do for your operation? Talk to us — or dive into the full research behind the bottlenecks.

Sources

  1. “The Connectivity Crisis Blocking AI Deployment in Life Sciences Manufacturing,” 2026 MasterControl research report.
  2. “FY 2025 Report on the State of Pharmaceutical Quality,” FDA-CDER Office of Pharmaceutical Quality.
  3. “FDA inspections in 2025: Heightened rigor, data-driven targeting, and increased surveillance,” by Cori Annapolen Goldberg et al, Reed Smith Client Alerts, Dec. 23, 2025.
  4. "2026 Regulatory Readiness Playbook for Life Sciences,” MasterControl e-book.